The Hemolung System
Three Components, One Integrated Solution for Acute Respiratory Failure. The HEMOLUNG is the world’s first and only fully-integrated, FDA cleared system for extracorporeal CO2 removal (ECCO2R). The HEMOLUNG removes carbon dioxide directly from the blood at blood flow rates between 350 – 550 mL/min which can mitigate the harmful effects of hypercapnia, respiratory acidosis, intubation and ventilator induced lung injuries. The HEMOLUNG is an innovative tool to manage acute respiratory failure while minimizing the risks and complexities of extracorporeal lung support.
|
Indication for Use |
The HEMOLUNG is indicated for respiratory support that provides extracorporeal carbon dioxide (CO2) removal from the patient`s blood for up to 5 days in adults with acute, reversible respiratory failure for whom ventilation of CO2 cannot be adequately or safely achieved using other available treatment options and continued clinical deterioration is expected. |
|
Membrane Surface Area |
0.59 m2 |
|
Membrane Material |
Heparin Coated Polypropylene |
|
Blood Flow Rate |
350 – 550 mL/min |
|
Sweep Gas Flow Rate |
0 – 10 L/min Room Air |
|
Catheter |
15.5 Fr Dual Lumen Jugular or Femoral Venous Catheter |
|
Priming Volume (Cartridge + Tubing + Catheter) |
259 mL |